Douglas J. Hughes is Director of Immunovant, Inc.. Currently has a direct ownership of 119,585 shares of IMVT, which is worth approximately $3.29 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 5,425 shares (Common Stock) at a price of $28.54 per share, resulting in proceeds of $154,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 120K
4.34% 3M change
5.13% 12M change
Total Value Held $3.29 Million

Douglas J. Hughes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2024
SELL
Open market or private sale
$154,829 $28.54 p/Share
5,425 Reduced 4.34%
119,585 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
11,255 Added 8.26%
125,010 Common Stock
Apr 12 2023
BUY
Grant, award, or other acquisition
-
12,523 Added 9.92%
113,755 Common Stock
Aug 17 2022
BUY
Grant, award, or other acquisition
-
21,059 Added 17.22%
101,232 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
21,726 Added 21.32%
80,173 Common Stock
Aug 27 2021
BUY
Open market or private purchase
$150,355 $8.24 p/Share
18,247 Added 23.79%
58,447 Common Stock
Mar 19 2021
BUY
Grant, award, or other acquisition
-
15,500 Added 27.83%
40,200 Common Stock

Also insider at

EAR
Eargo, Inc. Healthcare
DJH

Douglas J. Hughes

Director
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT